CY1108846T1 - Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της - Google Patents

Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της

Info

Publication number
CY1108846T1
CY1108846T1 CY20091100245T CY091100245T CY1108846T1 CY 1108846 T1 CY1108846 T1 CY 1108846T1 CY 20091100245 T CY20091100245 T CY 20091100245T CY 091100245 T CY091100245 T CY 091100245T CY 1108846 T1 CY1108846 T1 CY 1108846T1
Authority
CY
Cyprus
Prior art keywords
ace inhibitor
preparing
pharmaceutical composition
composition containing
improved pharmaceutical
Prior art date
Application number
CY20091100245T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Evangelos Kotzagiorgis
Dimitrios Bikiaris
Original Assignee
Pharmathen S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.
Publication of CY1108846T1 publication Critical patent/CY1108846T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται στην τυποποίηση στερεών μορφών δόσης για χορήγηση από το στόμα ή υπογλώσσια που περιλαμβάνουν μία θεραπευτικώς δραστική ποσότητα ενός αναστολέα ACE ή ενός φαρμακευτικώς ανεκτού άλατος αυτού, και ιδιαίτερα Fosinopril ή Trandolapril ή άλατα αυτών, σε συνδυασμό με ανόργανο πολυμερές πυρίτιο όπως το Dimethicone, και μία διαδικασία για την παρασκευή αυτών με άμεση συμπίεση.
CY20091100245T 2005-06-30 2009-03-03 Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της CY1108846T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20050100332A GR1006875B (el) 2005-06-30 2005-06-30 Βελτιωμενες φαρμακευτικες συνθεσεις περιεχουσες αναστολεις του μετατρεπτικου ενζυμου αγγειοτενσινης και μεθοδοι παρασκευης αυτων.
EP06765392A EP1906931B1 (en) 2005-06-30 2006-06-29 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof

Publications (1)

Publication Number Publication Date
CY1108846T1 true CY1108846T1 (el) 2014-07-02

Family

ID=38043070

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100245T CY1108846T1 (el) 2005-06-30 2009-03-03 Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της

Country Status (12)

Country Link
EP (1) EP1906931B1 (el)
AT (1) ATE415951T1 (el)
CA (1) CA2612742C (el)
CY (1) CY1108846T1 (el)
DE (1) DE602006004057D1 (el)
DK (1) DK1906931T3 (el)
ES (1) ES2318772T3 (el)
GR (1) GR1006875B (el)
HR (1) HRP20090102T3 (el)
PL (1) PL1906931T3 (el)
PT (1) PT1906931E (el)
WO (1) WO2007003972A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN114886866A (zh) * 2022-04-08 2022-08-12 苏州中化药品工业有限公司 一种格列齐特片(ⅱ)药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
JP2002535353A (ja) * 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物

Also Published As

Publication number Publication date
ATE415951T1 (de) 2008-12-15
HRP20090102T3 (en) 2009-03-31
GR1006875B (el) 2010-07-12
DE602006004057D1 (de) 2009-01-15
CA2612742C (en) 2010-08-03
CA2612742A1 (en) 2007-01-11
DK1906931T3 (da) 2009-03-09
PT1906931E (pt) 2009-02-12
PL1906931T3 (pl) 2009-05-29
WO2007003972A1 (en) 2007-01-11
EP1906931A1 (en) 2008-04-09
ES2318772T3 (es) 2009-05-01
GR20050100332A (el) 2007-01-19
EP1906931B1 (en) 2008-12-03

Similar Documents

Publication Publication Date Title
TN2010000011A1 (en) Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
BRPI0418228A (pt) forma de dosagem, e, métodos de tratamento de dor e de episódios de dor incidente de cáncer, e de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
MY149731A (en) Compounds
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
TW200626158A (en) Naphthaline derivatives
BR112012023780A2 (pt) compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
WO2008062476A3 (en) Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
TW200637817A (en) 5-aminoindole derivatives
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
CY1112702T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει εναν αντισπασμωδικο παραγοντα πυρρολιδονης και μεθοδος για την παρασκευη της
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
GR1006879B (el) Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουν αναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων
CY1108846T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της
ATE451385T1 (de) Verbindungen zur inhibierung von apoptose
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel
WO2006129056A3 (en) Process and novel salt
MY150480A (en) Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
AU2016219620A1 (en) Compositions and methods useful for treatment of respiratory illness
CY1110563T1 (el) Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου
ATE551998T1 (de) Feste pharmazeutische zusammensetzung mit tamsulosin